Blue Ice

Description

Vida Mia Blue Ice Gel is a topical formulation designed for external use. The gel exhibits a distinctive blue color and is packaged in a convenient dosage form suitable for application on the skin. The specific composition and inactive ingredients contribute to its intended therapeutic effects. The formulation is designed to provide a cooling sensation upon application, enhancing user experience.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains of muscles and joints associated with various conditions, including arthritis, simple backache, strains, bruises, and sprains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be cleaned prior to the application of the product. For adults and children aged 2 years and older, the product may be applied to the affected area up to 3 to 4 times daily. For children under 2 years of age, it is recommended to consult a physician before use.

Contraindications

Use of this product is contraindicated in patients who are concurrently using other topical pain relievers, as this may increase the risk of adverse effects. Additionally, the application of this product in conjunction with heating pads or heating devices is contraindicated due to the potential for enhanced skin irritation or burns.

Warnings and Precautions

For external use only. This product should not be used in conjunction with other topical pain relievers or with heating pads and heating devices, as these combinations may increase the risk of adverse effects.

When using this product, it is imperative to avoid contact with the eyes. The product should be applied only as directed, and it must not be applied to wounds or damaged skin. Additionally, users should refrain from tightly bandaging the area of application to prevent complications.

Healthcare professionals should advise patients to discontinue use and seek medical advice if the condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days. The appearance of redness or irritation at the application site also warrants cessation of use and consultation with a healthcare provider.

It is essential to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center should be made without delay.

Side Effects

Patients should be aware that this product is for external use only. It is contraindicated for use with other topical pain relievers and should not be used in conjunction with heating pads or heating devices.

During the use of this product, patients are advised to avoid contact with the eyes and to use the product only as directed. It should not be applied to wounds or damaged skin, and tight bandaging is not recommended.

Patients should discontinue use and consult a healthcare professional if the condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days. Additionally, if redness or irritation develops, medical advice should be sought.

For pregnant or breastfeeding individuals, it is recommended to consult a health professional prior to use. This product should be kept out of reach of children; in the event of ingestion, immediate medical assistance or contact with a Poison Control Center is necessary.

Drug Interactions

Co-administration of this medication with other topical pain relievers is contraindicated due to the potential for increased local irritation or adverse effects. It is essential to avoid the simultaneous use of heating pads or other heating devices, as this may enhance the risk of skin irritation or burns.

Healthcare professionals should monitor patients for any signs of adverse reactions when considering the use of this medication in conjunction with other topical agents or heat sources.

Packaging & NDC

Below are the non-prescription pack sizes of Blue Ice (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is advised.

For pediatric patients aged 2 years and older, the recommended application is to the affected area no more than 3 to 4 times daily. For children under 2 years of age, it is recommended to consult a physician before use.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of data necessitates careful clinical judgment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms may vary depending on the specific substance involved, and monitoring for any adverse effects is essential.

Management of overdosage should include supportive care and symptomatic treatment as necessary. Continuous assessment of the patient's condition is recommended to address any complications that may arise.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to inform patients that this product should not be used in conjunction with other topical pain relievers, as this may increase the risk of adverse effects.

Patients should be cautioned against using the product with heating pads or any heating devices, as this could lead to increased irritation or other complications. They should be instructed to discontinue use and consult a doctor if their condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days.

Additionally, patients should be made aware that they need to stop using the product and seek medical advice if they experience any redness or irritation. While using the product, patients must avoid contact with the eyes and should only use it as directed. It is also essential to inform them not to apply the product to wounds or damaged skin and to avoid tightly bandaging the area where the product is applied.

Storage and Handling

The product is supplied in a configuration that ensures optimal usability. It should be stored at room temperature to maintain its integrity and effectiveness. To prevent contamination and preserve quality, the lid must be kept tightly closed when not in use. Additionally, it is crucial to avoid using, pouring, spilling, or storing the product near heat sources or open flames to ensure safety and prevent degradation.

Additional Clinical Information

The medication is administered topically, with a recommended application frequency of 3 to 4 times daily for adults and children aged 2 years and older. For children under 2 years of age, it is advised to consult a doctor prior to use. Clinicians should counsel patients to seek professional advice if they are pregnant or breastfeeding before using the product.

No additional information is available regarding laboratory tests, abuse potential, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Blue Ice, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)